Fulton Breakefield Broenniman’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $334K | Hold |
1,978
| – | – | 0.02% | 144 |
|
|
2025
Q4 | $334K | Hold |
1,978
| – | – | 0.02% | 150 |
|
|
2025
Q3 | $286K | Sell |
1,978
-37
| -2% | -$5.05K | 0.02% | 168 |
|
|
2025
Q2 | $255K | Buy |
2,015
+37
| +2% | +$4.54K | 0.02% | 167 |
|
|
2025
Q1 | $253K | Sell |
1,978
-633
| -24% | -$85.8K | 0.02% | 155 |
|
|
2024
Q4 | $345K | Hold |
2,611
| – | – | 0.02% | 138 |
|
|
2024
Q3 | $380K | Sell |
2,611
-76
| -3% | -$11K | 0.03% | 130 |
|
|
2024
Q2 | $369K | Hold |
2,687
| – | – | 0.03% | 131 |
|
|
2024
Q1 | $369K | Hold |
2,687
| – | – | 0.03% | 132 |
|
|
2023
Q4 | $365K | Sell |
2,687
-28
| -1% | -$3.42K | 0.03% | 126 |
|
|
2023
Q3 | $332K | Buy |
2,715
+16
| +0.6% | +$2.04K | 0.03% | 134 |
|
|
2023
Q2 | $343K | Buy |
2,699
+12
| +0.4% | +$1.56K | 0.03% | 135 |
|
|
2023
Q1 | $347K | Sell |
2,687
-200
| -7% | -$26.2K | 0.03% | 131 |
|
|
2022
Q4 | $379K | Buy |
2,887
+1
| +0% | +$129 | 0.03% | 129 |
|
|
2022
Q3 | $338K | Hold |
2,886
| – | – | 0.03% | 127 |
|
|
2022
Q2 | $340K | Hold |
2,886
| – | – | 0.03% | 133 |
|
|
2022
Q1 | $376K | Sell |
2,886
-452
| -14% | -$58.9K | 0.03% | 122 |
|
|
2021
Q4 | $509K | Buy |
3,338
+452
| +16% | +$70K | 0.04% | 125 |
|
|
2021
Q3 | $467K | Sell |
2,886
-31
| -1% | -$5.22K | 0.04% | 117 |
|
|
2021
Q2 | $477K | Sell |
2,917
-29
| -1% | -$4.47K | 0.04% | 126 |
|
|
2021
Q1 | $444K | Buy |
2,946
+612
| +26% | +$97.2K | 0.04% | 124 |
|
|
2020
Q4 | $354K | Sell |
2,334
-573
| -20% | -$81.9K | 0.04% | 107 |
|
|
2020
Q3 | $394K | Sell |
2,907
-39
| -1% | -$5.29K | 0.04% | 126 |
|
|
2020
Q2 | $403K | Buy |
2,946
+200
| +7% | +$25.5K | 0.05% | 124 |
|
|
2020
Q1 | $296K | Sell |
2,746
-132
| -5% | -$15.2K | 0.04% | 125 |
|
|
2019
Q4 | $347K | Hold |
2,878
| – | – | 0.04% | 143 |
|
|
2019
Q3 | $286K | Buy |
+2,878
| New | +$301K | 0.04% | 150 |
|
|
2016
Q2 | – | Sell |
-31,218
| Closed | -$2.71M | – | 121 |
|
|
2016
Q1 | $2.71M | Sell |
31,218
-858
| -3% | -$76.7K | 0.59% | 62 |
|
|
2015
Q4 | $3.62M | Sell |
32,076
-1,248
| -4% | -$135K | 0.8% | 53 |
|
|
2015
Q3 | $3.37M | Sell |
33,324
-1,845
| -5% | -$221K | 0.79% | 56 |
|
|
2015
Q2 | $4.33M | Sell |
35,169
-381
| -1% | -$45.6K | 0.95% | 49 |
|
|
2015
Q1 | $4.07M | Buy |
35,550
+81
| +0.2% | +$8.93K | 0.91% | 49 |
|
|
2014
Q4 | $3.59M | Sell |
35,469
-90
| -0.3% | -$8.75K | 0.79% | 53 |
|
|
2014
Q3 | $3.24M | Buy |
35,559
+594
| +2% | +$52.1K | 0.76% | 55 |
|
|
2014
Q2 | $3M | Buy |
34,965
+2,409
| +7% | +$190K | 0.73% | 54 |
|
|
2014
Q1 | $2.56M | Buy |
+32,556
| New | +$2.71M | 0.66% | 56 |
|
Other funds holding IBB
CB
Fulton Breakefield Broenniman's IBB Position: Q1 2026 in Review
Fulton Breakefield Broenniman held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,978 shares worth $334K. The position accounts for 0.02% of the portfolio, ranked #144.
Fulton Breakefield Broenniman first reported a position in IBB in Q1 2014 and has held it in 36 quarters since. The position peaked at $4.33M in Q2 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Fulton Breakefield Broenniman held 1,978 shares of iShares Biotechnology ETF worth $334K as of Q1 2026.
- Fulton Breakefield Broenniman left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.02% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #144 holding.
- Fulton Breakefield Broenniman first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 36 quarters since.
- Fulton Breakefield Broenniman's iShares Biotechnology ETF position peaked at $4.33M in Q2 2015.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.